Business ❯Pharmaceutical Industry ❯Market Dynamics
Zepbound and Mounjaro Compounded Medications Compounding Pharmacies Eli Lilly Investment Profit Margins Supply Chain Issues
The resolution of the Ozempic and Wegovy shortage prompts regulatory deadlines for compounding pharmacies to cease production of cheaper alternatives.
